Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 11,505 | 11,753 | 9,007 | 7,721 | 13,034 |
| Cost of Goods | 2,581 | 2,671 | 2,249 | 2,439 | 1,422 |
| Gross Profit | 8,924 | 9,082 | 6,758 | 5,282 | 11,612 |
| Operating Expenses | 80,028 | 92,857 | 54,735 | 48,884 | 44,613 |
| Operating Income | -70,523 | -83,104 | -47,728 | -43,163 | -32,579 |
| Interest Expense | 2,494 | 2,562 | 8,295 | 6,806 | 6,989 |
| Other Income | 5,203 | -732 | -30,889 | -19,487 | -29,542 |
| Pre-tax Income | -67,814 | -86,398 | -86,912 | -69,456 | -69,110 |
| Income Tax | 36 | 145 | -1,919 | -276 | 309 |
| Net Income Continuous | -73,128 | -87,109 | -84,993 | -69,180 | -69,426 |
| Minority Interests | -1,625 | -3,086 | -7,253 | -3,985 | -6,606 |
| Net Income | $-71,503 | $-84,023 | $-77,740 | $-65,195 | $-62,820 |
| EPS Basic Total Ops | -0.25 | -0.33 | -0.36 | -0.36 | -0.37 |
| EPS Basic Continuous Ops | -0.25 | -0.35 | -0.39 | -0.38 | -0.38 |
| EPS Diluted Total Ops | -0.25 | -0.33 | -0.36 | -0.36 | -0.50 |
| EPS Diluted Continuous Ops | -0.26 | -0.34 | -0.39 | -0.38 | -0.31 |
| EBITDA(a) | $-55,409 | $-79,967 | $-45,133 | $-40,105 | $-29,838 |